X-Message-Number: 6513
From: Brian Wowk <>
Date: Fri, 12 Jul 1996 23:24:31 -0500
Subject: Technology Use Credits

	I agree that Prometheus technology should not be made
available on a royalty-free basis to cryonics organizations
(irrespective of their contribution level).  I think that the 
Prometheus company should charge on a per-patient basis for all use
of their technology.  This should be done not only to protect
the interests of investors, but to keep the company healthy and
able to continue research to perfect suspended animation of the
of the whole body.

	Instead of royalty-free access above a specific contribution
level, I suggest the following: The Prometheus company agree
to buy-back shares with "technology use credits."  In other words,
when a cryonics organization wishes to use Prometheus technology for a
patient, they can pay by returning shares to Prometheus instead of
paying royalities.  Individual shareholders would have this same
privilege. 

	Advantages of this plan:

*	Investment in Prometheus effectively becomes payment toward
	your own cryonics arrangements.

*	Regardless of the financial success of the company, Prometheus 
	shares will (once the technology becomes available) have
	an immediate market value in the cryonics community.
	The "technology use credits" they represent could help
	pay for the cryopreservation of yourself or loved ones,
	or be sold to other cryonicists at a market rate equal to
	the royalities they would otherwise have to pay.

*	This plan provides an enormous incentive to invest in 
	Prometheus NOW.  Those individuals and cryonics organizations
	who do not invest will have to ask themselves whether they
 	will be able to afford this technology at full market rates
	later.  It goes without saying that the royalities and
	"technology use credits" per share will be set so that
	paying royalties later will be much more expensive than
	purchasing shares now.

*	This plan is, above all, equitable.  It acknowledges that
	those people who step forward today to help make this technology
	a reality deserve affordable access to it.  Conversely, 
 	those who stay on the sidelines hoping to benefit from 
	a "tragedy of the commons" scenario, will in fact NOT benefit. 	

***************************************************************************
Brian Wowk          CryoCare Foundation               1-800-TOP-CARE
President           Human Cryopreservation Services   
   http://www.cryocare.org/cryocare/

Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=6513